Kathryn Kundrod

TL;DR: Both commercially available diagnostics and technologies that are currently in development to detect the leading causes of maternal and neonatal mortality are reviewed, highlighting key gaps in development where innovative design could increase access to technology and enable rapid diagnosis at the bedside.

TL;DR: Successful development, validation, and scaling of this sample-to-answer, extraction-free real-time RT-LAMP test for SARS-CoV-2 adds a highly adaptable tool to efforts to control the COVID-19 pandemic, and can inform test development strategies for future infectious disease threats.

TL;DR: The standard of care for cervical cancer screening and diagnosis in high- and low-resource settings, biomarkers that correlate to cervical precancer and cancer, and needs for new tests are discussed, with a focus on tests that are already in use in LMICs or have the potential to be adapted for use.

TL;DR: In this paper, the authors used real-time fluorescence to detect the point mutation encoding hemoglobin S (HbS) in one round of isothermal recombinase polymerase amplification (RPA).

TL;DR: The high capture efficiency and easy-to-operate nature of the macroporous materials with regular structures into microfluidic devices for affinity chromatography suit the needs of resource-limited settings and may find applications in point-of-care diagnostics.